Quick Answer
Lipocine Inc. reported Total Assets of $17.01 million for fiscal year 2025.
Lipocine Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $17.01M | -24.5% |
| 2024 | $22.51M | -2.1% |
| 2023 | $23.00M | -38.7% |
| 2022 | $37.54M | -28.5% |
| 2021 | $52.48M | +107.0% |
| 2020 | $25.35M | +29.0% |
| 2019 | $19.66M | -5.7% |
| 2018 | $20.85M | -17.7% |
| 2017 | $25.33M | -7.4% |
| 2016 | $27.34M | -39.7% |
| 2015 | $45.38M | +62.1% |
| 2014 | $27.99M | -39.3% |
| 2013 | $46.11M | +728.3% |
| 2012 | $5.57M | +17056.9% |
| 2011 | $32.4K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $16.07M | -22.3% | -13.5% |
| June 30, 2025 | $18.58M | -19.3% | -9.4% |
| March 31, 2025 | $20.50M | -19.4% | -8.9% |
| December 31, 2024 | $22.51M | -2.1% | +8.8% |
| September 30, 2024 | $20.70M | -16.4% | -10.1% |
| June 30, 2024 | $23.03M | -24.4% | -9.5% |
| March 31, 2024 | $25.45M | -25.2% | +10.6% |
| December 31, 2023 | $23.00M | -38.7% | -7.1% |
- Lipocine Inc. showed a decrease of -24.5% in Total Assets compared to the prior fiscal year.
- Over the 2011–2025 period, Lipocine Inc.’s total assets has grown by 52316.9% (from $32.4 thousand to $17.01 million).
- The most recent figure is from Lipocine Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: